Gout is the most common inflammatory arthritis and occurs when hyperuricaemia, sustained
elevation of serum urate levels resulting in supersaturation of body tissues with urate, leads …

Gout is the most prevalent form of inflammatory arthritis, with a strong impact on individual
health and healthcare systems. This article reviews clinical and experimental evidences …

Background: Sodium–glucose cotransporter-2 inhibitors (SGLT2is) decrease serum urate
levels, but whether this translates into prevention of recurrent flares among patients with …

Objective To use data from the Global Burden of Disease (GBD) Study 2019 to report the
global, regional and national rates and trends of annual incidence, point prevalence and …

Purpose of review We aim to provide a comprehensive review of the available literature to
inform dietary recommendations for patients with gout and hyperuricemia that have the …

Background Currently, it is not possible to predict whether patients with hyperuricemia
(HUA) will develop gout and how this progression may be affected by urate-lowering …

Objective Gout flares are followed by transient major cardiovascular (CV) risk, implicating
the role of inflammation; the aim of this study was to determine whether premature mortality …

Gout is the most common form of inflammatory arthritis worldwide and is characterized by
painful recurrent flares of inflammatory arthritis that are associated with a transiently …

Allopurinol is a commonly used medication that lowers uric acid production which is
essential for gout treatment and prevention. Although many patients tolerate allopurinol …

Objectives. Hospital admissions for gout flares have increased dramatically in recent years,
despite widely available, effective medications for the treatment and prevention of flares. We …